skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

26 Total results for product and free and sample content found

Pharmaprojects, Biomedtracker, Trialtrove

Epigenetic Drugs in Oncology: Current Clinical Landscape and Emerging Trends

By Rachel Meighan-Mantha 22 Mar 2017

Epigenetic Drugs in Oncology: Current Clinical Landscape and Emerging Trends

Topic Cancer Clinical trial optimization

Pink Sheet

AstraZeneca Mulls Broad Ovarian Cancer Maintenance Approval For Lynparza

By Emily Hayes 15 Mar 2017

Discussion with regulators on conditional regulatory pathways will now begin after strong and durable immune responses against the Zaire Ebola virus were reported in a UK-based Phase I trial in healthy volunteers usingthefiloviruses vaccine Ad26.ZEBOV developed by Bavarian Nordic AS and licensed by Johnson & Johnson'sJanssen Pharmaceutical Cos.

Topic Cancer Research Clinical trial optimization


What is new for refractory asthma therapies?

By Laura Runkel 09 Jan 2017

The past year has seen the approval of the first biologic drugs for the treatment of severe eosinophilic asthma, the anti-IL5 antibodies Cinquar (Teva) and Nucala (GlaxoSmithKline, GSK).

Topic Clinical trials Drug approval Clinical trial optimization


Kinase inhibitors in rheumatoid arthritis: where have they been and where are they going?

By ​Gunilla Sturrock 07 Dec 2016

This analysis provides a five year review of the RA kinase inhibitor programs – where have they been and where are they going.

Topic Clinical trial optimization


Collaborations in HIV treatment trials: A help or hindrance for patient recruitment?

By Doro Shin 07 Dec 2016

This analysis takes a closer look at Phase II-III studies in HIV positive patients in order to determine what effect collaboration has on enrollment trends in clinical trials evaluating antiretroviral treatment, if any.

Topic Clinical trial optimization


Innovation In Heart Failure Drug Development - Is There Enough?

By Jake Mathon 02 Dec 2016

Heart failure is a chronic condition that is of major concern to the healthcare community. 5.8 million Americans and 23 million people globally are estimated to have heart failure.

Topic Clinical trial optimization


Clinical trial landscape

By Christine Blazynski 25 Nov 2016

Due to popular demand, Christine has provided an encore of the landscape for 2015. In 2014 the analysis encompassed 4,301 Phase I through Phase III/IV completed and terminated trials; the top 3 diseases with completed trials were Type 2 diabetes, HCV and breast cancer.

Topic Clinical trial optimization


Partnering in the Pharma world: BIO-Europe® and industry trends 2012-2015

By Patricia Giglio 14 Nov 2016

Partnering came into use twenty-odd years ago when pharmaceutical companies began working with biotech and increasingly sought external discovery and development opportunities.

Topic Clinical trial optimization


From Solanezumab To Solithromycin: What To Watch For In Q4

11 Oct 2016

Lilly’s solanezumab, Roche/Genentech’s Ocrevus and Cempra’s solithromycin are among the key therapies scheduled for major data read-outs or approval decisions in Q4 2016.

Topic Clinical trial optimization

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: